Effect of Prematurity on Renal Function in 5 Years Old Children
NCT ID: NCT00817921
Last Updated: 2014-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
168 participants
OBSERVATIONAL
2008-11-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To evaluate the effect of prematurity on renal function in 5 years old children
2. To compare former premature children treated by ibuprofen in the neonatal period to controls
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ibuprofen and Renal Function in Premature Infants
NCT00217191
Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants
NCT02726178
No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
NCT02128191
The Preterm Infants' Paracetamol Study
NCT01938261
Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus
NCT04037514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
former premature children treated by ibuprofen
No interventions assigned to this group
2
former premature children not treated by ibuprofen
No interventions assigned to this group
3
former term children (control)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jean Michel Hascoet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean Michel Hascoet
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Michel HASCOET, MD
Role: PRINCIPAL_INVESTIGATOR
Maternite Regionale Universitaire
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Dijon, , France
AP-HM (Néonatologie)
Marseille, , France
Maternite Regionale Universitaire
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vieux R, Hascoet JM, Franck P, Guillemin F. Increased albuminuria in 4-year-old preterm-born children with normal height. J Pediatr. 2012 Jun;160(6):923-8.e1. doi: 10.1016/j.jpeds.2011.12.005. Epub 2012 Jan 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRU-07-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.